Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 3/20 | 0.51 |
| ▸ | TRPM8 | Q7Z2W7 | 5/20 | 0.50 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.50 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.40 |
| ▸ | TRPV1 | Q8NER1 | 4/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL11492237 | 0.98 | EPHX1 (0.50) | EPHX1TRPM8TRPA1KCNA5TRPV1 | |
| Menthol SCHEMBL4583912 | 0.92 | TRPM8 (0.66) | EPHX1TRPM8TRPA1KCNA5TRPV1 | |
| SCHEMBL10859205 | 0.85 | EPHX1 (0.51) | EPHX1TRPM8TRPA1KCNA5TRPV1 | |
| SCHEMBL10860099 | 0.84 | EPHX1 (0.50) | EPHX1TRPM8TRPA1KCNA5TRPV1 | |
| SCHEMBL9951257 | 0.83 | EPHX1 (0.53) | EPHX1TRPM8TRPA1KCNA5TRPV1 | |
| SCHEMBL1030886 | 0.83 | EPHX1 (0.53) | EPHX1TRPM8TRPA1KCNA5TRPV1 | |
| SCHEMBL9951715 | 0.83 | EPHX1 (0.53) | EPHX1TRPM8TRPA1KCNA5TRPV1 | |
| SCHEMBL3274993 | 0.83 | EPHX1 (0.53) | EPHX1TRPM8TRPA1KCNA5TRPV1 | |
| SCHEMBL16456973 | 0.82 | EPHX1 (0.49) | EPHX1TRPM8TRPA1KCNA5TRPV1 | |
| SCHEMBL112766 | 0.82 | EPHX1 (0.49) | EPHX1TRPM8TRPA1KCNA5TRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 104 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3758803-A1 | POLY(VINYLAMINE-VINYLFORMAMIDE) COPOLYMERS AS ANTIPERSPIRANT AGENT | Henkel AG & Co. KGaA (DE) | 2021-01-06 | — | — | EP | disclosed |
| EP-3166589-B1 | SWEAT-INHIBITING COSMETICS WITH PROTEINS FROM LEGUME OF GENUS PISUM, AND WHICH DO NOT CONTAIN ALUMINIUM AND/OR ZIRCONIUM HALOGENIDES AND/OR HYDROXYHALOGNIDES | HENKEL AG & CO KGAA (DE) | 2020-04-08 | — | — | EP | disclosed |
| EP-3621584-A1 | METHODS FOR REDUCING SWEAT AND/OR BODY ODOR, USING PHOSPHONATE COMPOUNDS WITH AMINE AND/OR HYDROXYL GROUPS | Henkel AG & Co. KGaA (DE) | 2020-03-18 | — | — | EP | disclosed |
| EP-3166588-B1 | USE OF A SPECIFIC PROTEIN TO REDUCE TRANSPIRATION OF THE BODY | HENKEL AG & CO KGAA (DE) | 2019-08-14 | — | — | EP | disclosed |
| EP-3515398-A1 | METHODS FOR REDUCING SWEAT AND/OR BODY ODOUR USING SPECIFIC ACIDS OR DERIVATIVES THEREOF | Henkel AG & Co. KGaA (DE) | 2019-07-31 | — | — | EP | disclosed |
| EP-3250294-B1 | ANTIPERSPIRANTS CONTAINING SALICYLIC ACID AND AMINOPOLYCARBOXYLIC ACID DERIVATIVES | HENKEL AG & CO KGAA (DE) | 2019-05-15 | — | — | EP | disclosed |
| EP-3209387-B1 | USE OF CHITOSANS IN ANTIPERSPIRANT COMPOSITIONS FREE OF HALOGEN OR HALOGENHYDROXYSALTS OF ALUMINUM AND OR ZIRCONIUM | HENKEL AG & CO KGAA (DE) | 2019-04-24 | — | — | EP | disclosed |
| EP-3191078-B1 | SWEAT-INHIBITING COSMETICS WITH PROTEINS FROM MALVAE OF GENUS ADANSONIA, AND WHICH DO NOT CONTAIN ALUMINIUM AND/OR ZIRCONIUM HALOGENIDES AND/OR HYDROXYHALOGNIDES | HENKEL AG & CO KGAA (DE) | 2019-03-20 | — | — | EP | disclosed |
| EP-2934466-B1 | TEXTILE-SPARING, NON-AEROSOL ANTIPERSPIRANTS WITH METHANESULPHONIC ACID | HENKEL AG & CO KGAA (DE) | 2019-02-06 | — | — | EP | disclosed |
| WO-2018206449-A1 | METHODS FOR REDUCING SWEAT AND/OR BODY ODOR, USING PHOSPHONATE COMPOUNDS WITH AMINE AND/OR HYDROXYL GROUPS | HENKEL AG & CO. KGAA (DE) | 2018-11-15 | — | — | WO | disclosed |
| EP-1888012-A2 | OIL-CONTAINING DEODORIZING AEROSOL COMPOSITIONS HAVING SKIN-COOLING ACTIVE SUBSTANCES | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2008-02-20 | — | — | EP | disclosed |
| EP-1885457-A1 | ANTIPERSPIRANT EMULSION SPRAY WITH HAIR GROWTH INHIBITOR | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2008-02-13 | — | — | EP | disclosed |
| EP-1824444-A1 | STORAGE-STABLE EMULSION SPRAY PRODUCT | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2007-08-29 | — | — | EP | disclosed |
| EP-1803660-A1 | Emulsion spray | Henkel Kommanditgesellschaft auf Aktien (DE) | 2007-07-04 | — | — | EP | disclosed |
| WO-2006128622-A2 | OIL-CONTAINING DEODORIZING AEROSOL COMPOSITIONS HAVING SKIN-COOLING ACTIVE SUBSTANCES | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2006-12-07 | — | — | WO | disclosed |
| WO-2006125582-A1 | ANTIPERSPIRANT EMULSION SPRAY WITH HAIR GROWTH INHIBITOR | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2006-11-30 | — | — | WO | disclosed |
| WO-2006063726-A1 | STORAGE-STABLE EMULSION SPRAY PRODUCT | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2006-06-22 | — | — | WO | disclosed |
| US-20050154051-A1 | Method for the preparation of escitalopram | H. LUNDBECK A/S (DK) | 2005-07-14 | — | — | US | disclosed |
| EP-1458701-A1 | METHOD FOR THE PREPARATION OF ESCITALOPRAM | H. Lundbeck A/S (DK) | 2004-09-22 | — | — | EP | disclosed |
| WO-2003051861-A1 | METHOD FOR THE PREPARATION OF ESCITALOPRAM | H. LUNDBECK A/S (DK) | 2003-06-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050154051-A1 | Method for the preparation of escitalopram | SLC6A4, TPH2, SLC6A3 | EPHX1 2281/4885TRPM8 3434/4885TRPA1 3192/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.